Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.42 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.40 |
| ▸ | IL1RN | P18510 | 1/20 | 0.35 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.35 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.35 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27587945 | 1.00 | MME (0.42) | MMETGFBR1IL1RNERAP2ERAP1 | |
| SCHEMBL31433192 | 0.89 | PTPN1 (0.46) | PTPN1NOD1 | |
| SCHEMBL2837128 | 0.87 | ECE1 (0.41) | MMETGFBR1IL1RNERAP2ERAP1 | |
| SCHEMBL28462912 | 0.87 | MME (0.56) | MMETGFBR1 | |
| SCHEMBL30095963 | 0.87 | MME (0.56) | MMETGFBR1 | |
| SCHEMBL20990382 | 0.84 | TGFBR1 (0.41) | MMETGFBR1IL1RNERAP2ERAP1 | |
| SCHEMBL27814307 | 0.84 | TGFBR1 (0.41) | MMETGFBR1IL1RNERAP2ERAP1 | |
| SCHEMBL30952095 | 0.84 | PTGS1 (0.39) | MMETGFBR1NOD1 | |
| SCHEMBL29749960 | 0.84 | MME (0.53) | MMETGFBR1 | |
| SCHEMBL22807651 | 0.84 | ACE (0.41) | MMEPTPN1NOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250386846-A1 | Food Compositions Including Aragonite | NANT HOLDINGS IP LLC (US) | 2025-12-25 | — | — | US | claimed |
| US-12089621-B2 | Beverage compositions including calcium supplied from aragonite and methods of making the same | NANT HOLDINGS IP, LLC (US) | 2024-09-17 | — | — | US | claimed |
| US-20230354865-A1 | Beverage Compositions Including Calcium Supplied From Aragonite And Methods Of Making The Same | NANT HOLDINGS IP, LLC | 2023-11-09 | — | — | US | claimed |
| US-11793224-B2 | Beverage compositions including calcium supplied from aragonite and methods of making the same | NANT HOLDINGS IP, LLC (US) | 2023-10-24 | — | — | US | claimed |
| US-20230085907-A1 | Beverage Compositions Including Calcium Supplied From Aragonite And Methods Of Making The Same | NANT HOLDINGS IP, LLC | 2023-03-23 | — | — | US | claimed |
| EP-2036551-B1 | CATECHINS FOR IMPROVING MUSCLE POWER | KAO CORP (JP) | 2013-11-06 | — | — | EP | disclosed |
| US-20090197944-A1 | AGENT FOR IMPROVING MUSCLE FORCE | KAO CORPORATION (JP) | 2009-08-06 | — | — | US | disclosed |
| EP-2036551-A1 | AGENT FOR IMPROVING MUSCLE POWER | Kao Corporation (JP) | 2009-03-18 | — | — | EP | disclosed |
| US-4822635-A | Sweetening with L-aminodicarboxylic acid esters | GENERAL FOODS CORPORATION (US) | 1989-04-18 | — | — | US | disclosed |
| US-4788073-A | Sweetening with L-aminodicarboxylic acid alkenes | GENERAL FOODS CORPORATION (US) | 1988-11-29 | — | — | US | disclosed |
| US-4788332-A | ARTIFICAL SWEETENER | GENERAL FOODS CORPORATION (US) | 1988-11-29 | — | — | US | disclosed |
| US-4781927-A | Sweetening with l-aminodicarboxylic acid esters | GENERAL FOODS CORPORATION (US) | 1988-11-01 | — | — | US | disclosed |
| US-4571308-A | L-Aminodicarboxylic acid aminoalkenoic acid ester amides | GENERAL FOODS CORPORATION (US) | 1986-02-18 | — | — | US | disclosed |
| US-4465626-A | Process for preparation, isolation and purification of dipeptide sweeteners | PFIZER INC. (US) | 1984-08-14 | — | — | US | disclosed |
| US-4465626-A | Process for preparation, isolation and purification of dipeptide sweeteners | PFIZER INC. (US) | 1984-08-14 | — | — | US | disclosed |
| EP-0074249-B1 | PROCESSES FOR PREPARATION, ISOLATION AND PURIFICATION OF DIPEPTIDE SWEETENERS | PFIZER INC. (US) | 1984-08-08 | — | — | EP | disclosed |
| EP-0074249-A1 | Processes for preparation, isolation and purification of dipeptide sweeteners | PFIZER INC. (US) | 1983-03-16 | — | — | EP | disclosed |
| EP-0074249-A1 | Processes for preparation, isolation and purification of dipeptide sweeteners | PFIZER INC. (US) | 1983-03-16 | — | — | EP | disclosed |
| US-4375430-A | Processes for preparation, isolation and purification of dipeptide sweeteners | PFIZER INC. (US) | 1983-03-01 | — | — | US | disclosed |
| US-4375430-A | Processes for preparation, isolation and purification of dipeptide sweeteners | PFIZER INC. (US) | 1983-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250386846-A1 | Food Compositions Including Aragonite | PLCG2, PLCG1, PLCB3 | MME 4746/4885TGFBR1 4583/4885IL1RN 3709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.